A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles

Dermatologic Surgery

Volumn 38, Issue 7 PART 2, 2012, Pages 1234-1243

  Smith, Stacy R ^a   Munavalli, Girish ^a   Weiss, Robert ^b   Maslowski, John M ^c   Hennegan, Kevin P ^d   Novak, Jeanne M ^d  

^a Maryland Laser Skin and Vein Institute ^*

^b Maryland Laser   (United States)

^c Fibrocell Technologies Inc   (United States)

^d CBR International Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; AUTOLOGOUS FIBROBLAST THERAPY; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASOLABIAL FOLD; PATIENT SAFETY; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VALIDATION STUDY; WRINKLE;

ADULT; AGED; CELL TRANSPLANTATION; COSMETIC TECHNIQUES; DOUBLE-BLIND METHOD; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; NASOLABIAL FOLD; SKIN AGING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84863723827     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2012.02349.x     Document Type: Article

References (28)

1. Cosmetic Surgery National Data Bank Statistics. American Society for Aesthetic Plastic Surgery; 2010 [Online] Available:.
2. Fagien S, Klein AW,. A brief overview and history of temporary fillers: evolution, advantages, and limitations. Plast Reconstr Surg 2007; 120: 8S-16S.
3. Burgess CM,. Principles of soft tissue augmentation for the aging face. Clin Interv Aging 2006; 1: 349-55.
4. Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, et al. The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A 2011; 17: 2221-30.
5. Weiss RA, Weiss MA, Beasley KL, Munavalli G,. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg 2007; 33: 263-8.
6. Lemperle G, Holmes RE, Cohen SR, Lemperle SM,. A classification of facial wrinkles. Plast Reconstr Surg 2001; 108: 1735-50. discussion 51-2.
7. Narins RS, Brandt F, Leyden J, Rubin M, Smith S,. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588-95.
8. Baumann LS, Shamban AT, Lupo MP, Monheit GD, et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg 2007; 33 (Suppl 2): S128-35.
9. Narins RS, Brandt FS, Lorenc ZP, Maas CS, et al. A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds. Dermatol Surg 2007; 33 (Suppl 2): S213-21. discussion S21.
10. Cohen SR, Berner CF, Busso M, Gleason MC, et al. ArteFill: a long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg 2006; 118: 64S-76S.
11. Carruthers A, Carey W, De Lorenzi C, Remington K, et al. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg 2005; 31: 1591-8. discussion 98.
12. Narins RS, Baumann L, Brandt FS, Fagien S, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol 2010; 62: 448-62.
13. Moers-Carpi M, Vogt S, Santos BM, Planas J, et al. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 2007; 33 (Suppl 2): S144-51.
14. Bass LS, Smith S, Busso M, McClaren M,. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J 2010; 30: 235-8.
15. Smith SR, Jones D, Thomas JA, Murphy DK, Beddingfield FC, 3rd. Duration of wrinkle correction following repeat treatment with Juvederm hyaluronic acid fillers. Arch Dermatol Res 2010; 302: 757-62.
16. Narins RS, Brandt FS, Lorenc ZP, Maas CS, Monheit GD, Smith SR,. Twelve-month persistency of a novel ribose-cross-linked collagen dermal filler. Dermatol Surg 2008; 34 (Suppl 1): S31-9.
17. Narins RS, Dayan SH, Brandt FS, Baldwin EK, et al. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 2008; 34 (Suppl 1): S2-8. discussion S8.
18. Van Dorp AG, Verhoeven MC, Koerten HK, Van Der Nat-Van Der Meij TH, et al. Dermal regeneration in full-thickness wounds in Yucatan miniature pigs using a biodegradable copolymer. Wound Repair Regen 1998; 6: 556-68.
19. Lamme EN, Van Leeuwen RT, Brandsma K, Lamme EN, Van Leeuwen RT, Brandsma K,. Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation. J Pathol 2000; 190: 595-603.
20. Krejci NC, Cuono CB, Langdon RC, McGuire J,. In vitro reconstitution of skin: fibroblasts facilitate keratinocyte growth and differentiation on acellular reticular dermis. J Invest Dermatol 1991; 97: 843-8.
21. Spiekstra SW, Breetveld M, Rustemeyer T, Scheper RJ, Gibbs S,. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen 2007; 15: 708-17.
22. Cohen JL,. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34 (Suppl 1): S92-9.
23. Hirsch RJ, Stier M,. Complications of soft tissue augmentation. J Drugs Dermatol 2008; 7: 841-5.
24. Smith KC,. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations. Dermatol Online J 2008; 14: 3.
25. Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L,. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64: 1-34.quiz 35-6.
26. Barnas JL, Simpson-Abelson MR, Brooks SP, Kelleher RJ, Jr, Bankert RB,. Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors. J Immunol 2010; 185: 2681-92.
27. Kummermehr J, Malinen E, Freykowski S, Sund M, Trott KR,. The influence of autologous tumor fibroblasts on the radiosensitivity of squamous cell carcinoma megacolonies. Int J Radiat Oncol Biol Phys 2001; 50: 229-37.
28. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146: 283-7.